Mattias Levin (Former)
1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell-dependent tumor immunity and synergizes with PD-1 blockade
(2025) In Cancer immunology research
- Contribution to journal › Article
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
- Contribution to journal › Article
- 2021
-
Mark
Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy
- Contribution to journal › Article
- 2017
-
Mark
Antibody-encoding repertoires of bone marrow and peripheral blood-a focus on IgE
- Contribution to journal › Letter
- 2016
-
Mark
Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapy.
- Contribution to journal › Article
- 2015
-
Mark
A folded and immunogenic IgE-hyporeactive variant of the major allergen Phl p 1 produced in Escherichia coli.
- Contribution to journal › Article
-
Mark
A microarray-based reaction rate analysis platform. Is there evidence of validity?
- Contribution to journal › Letter
- 2014
-
Mark
Human IgE against the major allergen Bet v 1 - defining an epitope with limited cross-reactivity between different PR-10 family proteins.
- Contribution to journal › Article
-
Mark
The human IgE repertoire
- Contribution to journal › Scientific review
-
Mark
Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.
- Contribution to journal › Article
